Peripheral Vascular Devices Market Size, Share and Forecast 2032

Market Overview

The global peripheral vascular devices market is projected to grow from USD 10,090.50 million in 2023 to USD 16,821.66 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.60%.

The global peripheral vascular devices market is driven by the increasing prevalence of peripheral artery diseases (PAD) and rising geriatric populations, which are more susceptible to vascular conditions. Advancements in technology, such as minimally invasive procedures and enhanced device designs, also play a significant role in market growth by offering improved treatment options with shorter recovery times. The growing adoption of peripheral vascular interventions in hospitals and clinics, coupled with increasing awareness about early diagnosis and treatment of vascular disorders, further contributes to market expansion. Additionally, the demand for better quality and cost-effective treatments is fostering innovation, particularly in the development of devices like stents, catheters, and balloons. Emerging markets, especially in Asia-Pacific and Latin America, are also fueling growth as healthcare infrastructure improves and more patients gain access to advanced vascular care options. These trends are expected to continue driving the market over the forecast period.

The global peripheral vascular devices market is experiencing significant growth across various regions, driven by the increasing prevalence of peripheral artery disease (PAD) and technological advancements in medical devices. North America and Europe dominate the market, owing to their well-established healthcare infrastructure, high adoption rates of advanced vascular treatments, and a growing aging population. In contrast, the Asia-Pacific region is witnessing rapid growth due to improving healthcare access, rising disposable incomes, and increased awareness of vascular health. Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Cook Medical, Koninklijke Philips N.V., AngioDynamics, Inc., and Biotronik SE & Co. KG. These companies are focusing on expanding their product portfolios, investing in research and development, and forming strategic partnerships to strengthen their position in the competitive landscape and meet the growing demand for innovative peripheral vascular solutions.

Market Insights

• The global peripheral vascular devices market was valued at USD 10,090.50 million in 2023 and is expected to reach USD 16,821.66 million by 2032, growing at a CAGR of 6.60%.
• Increasing prevalence of peripheral artery disease (PAD) and the aging population are driving the demand for vascular devices globally.
• Advancements in minimally invasive procedures and technological innovations, such as drug-eluting stents and bioresorbable devices, are shaping market trends.
• The market faces challenges such as high device costs and regulatory hurdles, limiting widespread adoption in certain regions.
• Key players include Abbott Laboratories, Medtronic, Boston Scientific, and Terumo Corporation, focusing on product innovation and strategic partnerships to expand their market presence.
• North America holds the largest market share, followed by Europe, due to their advanced healthcare infrastructure and high adoption rates of peripheral vascular devices.
• The Asia-Pacific region is growing rapidly, driven by increasing healthcare access, awareness, and rising disposable incomes.

Market Drivers

Rising Prevalence of Peripheral Artery Diseases (PAD)

The increasing incidence of peripheral artery diseases (PAD) is one of the key drivers for the global peripheral vascular devices market. PAD, a condition caused by the narrowing or blockage of blood vessels in the legs and arms, affects millions worldwide, particularly among the aging population. For instance, in 2019, the number of people aged 40 years and older with PAD was 113 million globally. As lifestyle factors such as smoking, poor diet, and lack of physical activity continue to contribute to the rise in vascular diseases, the demand for effective treatment solutions, including peripheral vascular devices, has grown. Early diagnosis and intervention are critical in managing PAD, further boosting the need for these devices.

Aging Population and Changing Demographics

The global aging population is another crucial factor propelling market growth. As people age, they are more likely to develop vascular diseases due to the natural decline in blood vessel elasticity and circulation. For instance, the prevalence of PAD in individuals aged 80-84 years is approximately 14.91%. With a significant portion of the world’s population entering older age brackets, there is a rising demand for vascular care solutions. This demographic shift, particularly in regions like North America and Europe, is expected to further drive the adoption of peripheral vascular devices, as elderly patients are more prone to PAD and require effective treatment options.

Technological Advancements in Peripheral Vascular Devices

Ongoing technological advancements are significantly influencing the growth of the peripheral vascular devices market. The development of minimally invasive devices, such as drug-coated balloons, stents, and thrombectomy systems, has improved the treatment of peripheral vascular diseases. These innovations offer several advantages, including reduced procedure times, smaller incisions, and shorter recovery periods, driving their adoption in healthcare settings. Additionally, advancements in biocompatible materials and imaging technologies have enhanced the performance and precision of these devices, expanding their use in various medical procedures.

Increasing Awareness and Access to Healthcare

Increasing awareness about peripheral vascular diseases and advancements in treatment options has also contributed to market growth. Public and private healthcare initiatives have focused on educating both patients and healthcare providers about early diagnosis and intervention. For instance, the "Get a Pulse on PAD" campaign by the Society for Vascular Surgery aims to raise awareness and promote early diagnosis of PAD. Additionally, improved access to healthcare in emerging markets, particularly in Asia-Pacific and Latin America, has driven the adoption of peripheral vascular devices. As healthcare infrastructure improves in these regions, more patients are gaining access to advanced vascular treatments, further boosting demand for peripheral vascular devices.

Market Trends

Minimally Invasive Procedures Gaining Popularity

A prominent trend in the global peripheral vascular devices market is the increasing shift toward minimally invasive procedures. With the rise in demand for quicker recovery times and reduced hospital stays, healthcare providers are favoring advanced devices that offer less invasive options for treating peripheral artery diseases. Techniques such as angioplasty, endovenous laser treatments, and catheter-based procedures are becoming more common, as they minimize surgical risks and complications. For instance, minimally invasive procedures now account for nearly 70% of all global surgeries, significantly reducing pain and recovery times. This trend is driving innovation in device design, with manufacturers focusing on creating smaller, more effective devices that facilitate these procedures.

Focus on Customization and Patient-Centric Devices

A growing trend in the peripheral vascular devices market is the focus on customization and patient-centric solutions. Device manufacturers are increasingly tailoring their products to meet the specific needs of individual patients, considering factors such as disease severity, anatomical differences, and lifestyle. For instance, the development of drug-coated balloons, bioresorbable stents, and other innovative technologies is enhancing the efficacy and long-term outcomes of vascular interventions. This trend is evident in the growing demand for personalized stents, balloons, and catheter systems designed for optimal patient outcomes. As healthcare providers prioritize patient satisfaction and outcomes, the market is seeing an increase in the development of devices that offer greater comfort, flexibility, and precision.

Integration of Smart Technologies

The integration of smart technologies in peripheral vascular devices is another key trend. Modern devices are incorporating advanced features such as wireless connectivity, real-time monitoring, and data analytics, which improve treatment outcomes and patient care. These technologies enable physicians to track the progress of treatments, adjust settings for optimal performance, and monitor patients remotely. The rise of digital health and the growing interest in data-driven healthcare solutions are influencing the development of smarter devices that not only enhance clinical procedures but also provide valuable insights into patient health.

Increasing Adoption in Emerging Markets

As healthcare systems improve in emerging markets, particularly in Asia-Pacific, Latin America, and the Middle East, there is a noticeable uptick in the adoption of peripheral vascular devices. These regions are experiencing greater access to advanced medical technologies due to rising healthcare investments and infrastructure improvements. The demand for vascular treatments is growing, fueled by a combination of higher disease prevalence, an aging population, and greater awareness of vascular health. Manufacturers are targeting these regions by offering cost-effective, high-quality devices, contributing to the market’s global expansion.

Market Challenges Analysis

Regulatory Hurdles and Market Entry Barriers

Regulatory approval processes and market entry barriers also present challenges for peripheral vascular device manufacturers. The approval process for medical devices, particularly those used in critical treatments like vascular interventions, can be lengthy, complex, and expensive. Manufacturers must adhere to stringent regulations imposed by authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). For instance, the Registry Assessment of Peripheral Interventional Devices (RAPID) project aims to standardize core data elements to streamline the approval process and improve device evaluation. These regulations are necessary for patient safety but can delay product launches and limit market expansion. Additionally, competition within the market is intensifying, with numerous players vying for market share. Smaller manufacturers may find it difficult to navigate the regulatory landscape, particularly in regions with varying standards, adding another layer of complexity to the industry.

High Cost of Peripheral Vascular Devices

One of the significant challenges faced by the global peripheral vascular devices market is the high cost associated with advanced devices and procedures. The development of cutting-edge technologies, such as drug-eluting stents and bioresorbable devices, often leads to higher production costs, which are subsequently passed on to healthcare providers and patients. This cost barrier can limit access to these devices, particularly in low-income and emerging markets where healthcare budgets are constrained. Additionally, while minimally invasive procedures offer numerous benefits, the expenses related to the required specialized equipment and skilled professionals can further exacerbate financial pressures on healthcare systems, impacting the overall adoption rate.

Market Opportunities

Expanding Market in Emerging Economies

The global peripheral vascular devices market presents significant opportunities in emerging economies, particularly in regions such as Asia-Pacific, Latin America, and the Middle East. As healthcare infrastructure improves in these regions, there is increasing access to advanced medical technologies, which is fueling demand for peripheral vascular devices. The rising prevalence of peripheral artery diseases (PAD), coupled with a growing geriatric population, is driving the need for effective treatment solutions. Moreover, the improving economic conditions and government initiatives to enhance healthcare access are creating a favorable environment for the adoption of these devices. Manufacturers can capitalize on this trend by offering cost-effective yet high-quality devices tailored to the needs of these markets.

Technological Advancements and Product Innovation

Another lucrative opportunity lies in the continued advancement of peripheral vascular device technologies. Ongoing innovation in minimally invasive procedures, smart devices, and biologically compatible materials is reshaping the landscape of vascular treatments. The development of drug-eluting stents, bioresorbable scaffolds, and next-generation catheter systems provides the potential for improved patient outcomes and greater procedural efficiency. Manufacturers that invest in R&D to create cutting-edge, patient-centric solutions will be well-positioned to capture market share. Additionally, incorporating digital technologies such as real-time monitoring and data analytics into devices can further enhance their value proposition, catering to the growing demand for precision medicine and personalized care. These technological advancements open up numerous opportunities for both established companies and new entrants in the market.

Market Segmentation Analysis:

By Type:

The global peripheral vascular devices market is categorized by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons hold a significant share, as they are commonly used in peripheral artery disease (PAD) treatments to dilate narrowed or blocked arteries. Angioplasty stents also play a crucial role in maintaining blood vessel patency and preventing restenosis, contributing to the growth of the market. Catheters and guidewires are indispensable tools in vascular procedures, enabling precise navigation and effective treatment delivery. The "others" segment includes various devices like thrombectomy systems and vascular grafts, which address specialized needs within the peripheral vascular treatment landscape. The continued innovation in these devices, such as drug-eluting and bioresorbable stents, is expected to drive segment growth further. Technological advancements, such as minimally invasive procedures and the development of personalized treatment options, are likely to enhance the adoption of these devices, expanding their market share across regions.

By End-user: The market is further segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market due to their advanced infrastructure, specialized medical teams, and a wide range of patients requiring peripheral vascular treatments. ASCs are witnessing significant growth, driven by the increasing preference for outpatient services and minimally invasive procedures that can be performed on an outpatient basis. These centers provide cost-effective alternatives for patients and healthcare providers, contributing to market expansion. Specialty clinics, focused on treating specific vascular conditions, are also playing an essential role in the growth of the market, especially in regions where there is a high demand for specialized vascular care. With the increasing number of vascular disease cases, the demand for these facilities and the corresponding peripheral vascular devices is set to rise, contributing to the overall market growth across all segments.

Segments:

Based on Type:

• Angioplasty Balloons
• Angioplasty Stents
• Catheters
• Guidewires
• Others

Based on End-user:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Based on the Geography:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Russia
  • Belgium
  • Netherlands
  • Austria
  • Sweden
  • Poland
  • Denmark
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Thailand
  • Indonesia
  • Vietnam
  • Malaysia
  • Philippines
  • Taiwan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Peru
  • Chile
  • Colombia
  • Rest of Latin America
• Middle East
  • UAE
  • KSA
  • Israel
  • Turkey
  • Iran
  • Rest of Middle East
• Africa
  • Egypt
  • Nigeria
  • Algeria
  • Morocco
  • Rest of Africa

Regional Analysis

North America

North America holds the largest market share, accounting for approximately 40% of the global market in 2023. This dominant position is driven by the high prevalence of peripheral artery disease (PAD), well-established healthcare infrastructure, and the availability of advanced medical technologies. The U.S., in particular, is a major contributor due to its large healthcare spending and the widespread adoption of innovative vascular treatments. Furthermore, the aging population in North America and the increasing demand for minimally invasive procedures are expected to sustain market growth in the region over the forecast period.

Europe

Europe follows North America with a market share of around 30%. The region benefits from a robust healthcare system and an aging population, which contributes to a higher incidence of vascular diseases. Countries such as Germany, the UK, and France are seeing an increase in the adoption of peripheral vascular devices, particularly as awareness of PAD and the benefits of early intervention rises. The European market is also witnessing technological advancements, including the introduction of bioresorbable stents and drug-eluting devices, which are driving demand. Additionally, healthcare reforms and improving access to advanced medical technologies are expected to contribute to market growth.

Asia-Pacific

In the Asia-Pacific region, the peripheral vascular devices market is experiencing significant growth, with an expected market share of around 20%. The increasing prevalence of cardiovascular diseases, expanding healthcare infrastructure, and rising disposable incomes are the primary factors driving this growth. Emerging markets like China, India, and Japan are witnessing higher adoption rates of peripheral vascular devices as healthcare accessibility improves. Moreover, the rapid urbanization and a growing awareness of vascular health are influencing patient demand for innovative vascular treatments. The shift towards outpatient procedures in ambulatory surgical centers (ASCs) in the region also contributes to market expansion.

Rest of the World (RoW)

The Rest of the World (RoW) region, comprising Latin America, the Middle East, and Africa, is expected to contribute around 10% to the global market share. In these regions, there is a growing demand for peripheral vascular devices, driven by a rise in the prevalence of PAD, an aging population, and improving healthcare systems. Latin America is seeing increasing healthcare investments, which support the adoption of advanced medical technologies, including peripheral vascular devices. In the Middle East and Africa, improving healthcare access, especially in countries like Saudi Arabia and the UAE, is boosting the market, although the rate of adoption is slower compared to other regions. Despite these challenges, the RoW region is expected to experience gradual growth as healthcare infrastructure improves and awareness of vascular diseases increases.

Key Player Analysis

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• Becton, Dickinson and Company
• Cardinal Health
• Cook Medical
• Koninklijke Philips N.V.
• AngioDynamics, Inc.
• Biotronik SE & Co. KG

Competitive Analysis

The global peripheral vascular devices market is highly competitive, with key players focusing on technological advancements, product innovation, and strategic partnerships to strengthen their market positions. Leading companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Cook Medical, Koninklijke Philips N.V., AngioDynamics, Inc., and Biotronik SE & Co. KG are dominating the market through their diverse product portfolios and strong distribution networks. These companies are leveraging their R&D capabilities to introduce new and advanced devices, such as drug-eluting stents, bioresorbable scaffolds, and next-generation angioplasty balloons, to meet the growing demand for minimally invasive treatments. For instance, Boston Scientific's Eluvia™ Drug-Eluting Vascular Stent System has shown promising results in reducing restenosis rates in patients with peripheral artery disease. Strategic acquisitions, partnerships, and collaborations are also integral to the growth strategies of these players, enabling them to expand their global footprint and strengthen their competitive edge. For instance, Medtronic's acquisition of Mazor Robotics has enhanced its product offering in the vascular device segment. Additionally, players are focusing on emerging markets in Asia-Pacific and Latin America, where increasing healthcare access and rising demand for vascular treatments present new growth opportunities. Companies are also working towards reducing the cost of devices to cater to a larger patient base, especially in price-sensitive regions. As the market becomes more competitive, innovation and strategic initiatives will be crucial for sustained growth.

Recent Developments

• In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
• In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD's ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
• In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
• In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The global peripheral vascular devices market exhibits moderate to high concentration, with several key players dominating the market. The presence of major companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and others indicates a competitive landscape driven by innovation and strong distribution networks. These companies focus on expanding their market share through product diversification, technological advancements, and strategic collaborations. Many of them invest heavily in research and development to introduce next-generation devices, such as drug-eluting stents, bioresorbable scaffolds, and minimally invasive angioplasty balloons, to cater to the growing demand for effective treatments in peripheral artery disease (PAD). The market is characterized by a high degree of product innovation, as manufacturers continually strive to develop devices that offer improved clinical outcomes, better patient safety, and enhanced ease of use. Additionally, regulatory approvals play a significant role in the market, with companies needing to comply with stringent guidelines to ensure the quality and safety of their devices. Another notable characteristic is the rising trend towards minimally invasive procedures, which has contributed to the growing adoption of peripheral vascular devices. As the market continues to evolve, smaller players and new entrants may find it challenging to compete with established giants, though they could carve out niches by focusing on specific product innovations or regional opportunities.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. Integration of digital technologies such as artificial intelligence and machine learning in device development will enhance diagnostic and treatment precision.
2. The increasing focus on patient-centric care and improving healthcare infrastructure in developing regions will support market expansion.
3. Favorable reimbursement policies in developed regions will facilitate broader adoption of peripheral vascular devices.
4. The shift toward less invasive treatments will encourage the growth of devices like angioplasty balloons and guidewires, which offer shorter recovery times.
5. Growing investment in R&D by key players will lead to the development of next-generation vascular devices with improved functionality and safety.
6. Rising demand for preventive care and early intervention strategies will drive the adoption of peripheral vascular devices for both diagnosis and treatment.
7. Key players will focus on expanding their presence in emerging economies by introducing affordable, region-specific product lines.
8. The expansion of digital health platforms and telemedicine will improve patient monitoring and management, increasing the demand for advanced vascular devices.
9. Environmental sustainability concerns may prompt companies to adopt more eco-friendly manufacturing processes and materials for their devices.
10. Increasing collaboration between healthcare providers and medical device manufacturers will facilitate the development of comprehensive solutions for peripheral vascular treatments.

Rising Prevalence of Peripheral Artery Diseases (PAD)

The increasing incidence of PAD, particularly among aging populations, is driving demand for peripheral vascular devices as more patients require effective interventions to restore blood flow and prevent complications.

Technological Advancements in Minimally Invasive Devices

Innovations such as drug-eluting stents, bioresorbable scaffolds, and advanced catheters are making procedures safer, more effective, and less invasive, encouraging broader adoption in clinical practice.

Aging Global Population

As the proportion of elderly individuals rises worldwide, the prevalence of vascular diseases increases, leading to greater need for peripheral vascular interventions and devices tailored to older patients.

Improved Healthcare Access in Emerging Markets

Expanding healthcare infrastructure and rising awareness in regions like Asia-Pacific and Latin America are enabling more patients to access advanced vascular treatments, fueling market growth.

Increasing Focus on Early Diagnosis and Preventive Care

Public health initiatives and campaigns are raising awareness about PAD and the benefits of early intervention, resulting in higher diagnosis rates and increased utilization of peripheral vascular devices.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.